COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #140
Source   PDF   Share   Tweet
See all 143 studies
10/8
Positive
Late treatment study
Aparisi et al., medRxiv, doi:10.1101/2020.10.06.20207092 (Preprint)
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
Retrospective 654 hospitalized patients focused on low-density lipoprotein cholesterol levels, also showing results for HC Q with 605 HC Q patients, unadjusted 30 day mortality relative risk RR 0.37, p = 0.008.
death, ↓63.0%, p=0.008
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit